AstraZeneca PLC ADR falls Thursday, underperforms market

This post was originally published on this site

© Terrence Horan


The AstraZeneca PLC ADR AZN shed 1.41% to $50.19 Thursday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index COMP rising 2.56% to 13,067.48 and the Dow Jones Industrial Average DJIA rising 0.69% to 31,041.13. The ADR’s fall snapped a three-day winning streak. AstraZeneca PLC ADR closed $14.75 short of its 52-week high ($64.94), which the company achieved on July 20th.

The ADR underperformed when compared to some of its competitors Thursday, as AbbVie Inc. ABBV rose 1.07% to $106.71, Amgen Inc. AMGN rose 0.33% to $234.02, and Gilead Sciences Inc. GILD rose 0.92% to $62.52. Trading volume (13.6 M) eclipsed its 50-day average volume of 10.2 M.

Editor’s Note: This story was auto-generated by Automated Insights using data from Dow Jones and FactSet. See our market data terms of use.

Continue Reading